Agios' Lewis Cantley returns with a new company and, he claims, a major oncological discovery
Lewis Cantley was a bit confused when he got an email from a graduate student who wanted to come to his Cornell lab and work on a semi-obscure phenomenon in cell biology: Lagging chromosomes.
“I said ‘I don’t know much about lagging chromosomes,'” Cantley, who became famous for discovering the PI3K pathway and its role in cancer, told Endpoints News.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 117,600+ biopharma pros reading Endpoints daily — and it's free.